Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Which of the following drugs does NOT have high hepatic clearance?

Paracetamol. ### Explanation The concept of **Hepatic Clearance** depends on the **Extraction Ratio (ER)**. Drugs with a high ER (>0.7) are cleared rapidly by the liver, meaning their clearance is limited by hepatic blood flow (Flow-dependent clearance). Drugs with a low ER (<0.3) are cleared slowly, and their clearance depends on the metabolic capacity of enzymes (Capacity-limited clearance). **1. Why Paracetamol is the correct answer:** Paracetamol has a **low hepatic extraction ratio**. While it is primarily metabolized by the liver (glucuronidation and sulfation), the process is relatively slow compared to hepatic blood flow. Therefore, it does not undergo extensive first-pass metabolism to the same degree as high-ER drugs, and its systemic bioavailability is high (approx. 70-90%). **2. Why the other options are incorrect:** * **Labetalol:** This is a classic example of a drug with a **high extraction ratio**. It undergoes significant first-pass metabolism, leading to lower oral bioavailability. * **Simvastatin:** This is a prodrug with very high hepatic extraction. It is specifically taken up by the liver (its target organ) during the first pass, resulting in less than 5% systemic bioavailability. * **Morphine:** Morphine undergoes extensive first-pass metabolism (primarily glucuronidation), giving it a high hepatic clearance. This is why the oral dose of morphine must be significantly higher than the parenteral dose to achieve the same effect. **Clinical Pearls for NEET-PG:** * **High ER Drugs (Mnemonic: "LIVS"):** **L**idocaine, **I**sosorbide dinitrate, **V**erapamil, **S**albutamol. Also includes Propranolol, Nitroglycerin, and Pethidine. * **Flow-dependent clearance:** For high ER drugs, any condition that decreases hepatic blood flow (e.g., Congestive Heart Failure, Propranolol) will decrease their clearance. * **Bioavailability:** Drugs with high hepatic clearance always have low oral bioavailability.

Q: The mechanism of action of protamine, an antidote for heparin, is based on which of the following?

Chemical antagonism. **Explanation:** **1. Why Chemical Antagonism is Correct:** Chemical antagonism occurs when two substances combine in solution, resulting in the chemical neutralization of the drug's effect without involving a specific biological receptor. **Heparin** is a highly acidic, negatively charged molecule (polyanion). **Protamine sulfate** is a strongly basic, positively charged protein (polycation). When administered, protamine binds ionically to heparin to form a stable, inactive **salt complex**. This direct chemical interaction neutralizes heparin’s anticoagulant activity, making it a classic example of chemical antagonism. **2. Why Other Options are Incorrect:** * **A. Competitive Antagonism:** This involves two drugs competing for the same receptor site (e.g., Atropine vs. Acetylcholine at muscarinic receptors). Protamine does not bind to the antithrombin III receptor site; it binds to the drug itself. * **C. Non-competitive Antagonism:** This occurs when an antagonist binds to an allosteric site or irreversibly to the receptor, preventing the agonist from producing a maximal effect. Again, this requires a receptor-mediated mechanism, which is absent here. * **D. Toxic Reaction:** While protamine can have side effects (like hypotension or anaphylaxis), its primary therapeutic mechanism is neutralization, not toxicity. **3. NEET-PG High-Yield Clinical Pearls:** * **Dosage:** 1 mg of protamine neutralizes approximately 100 units of heparin. * **Source:** Protamine is derived from **salmon sperm**; patients with fish allergies or those who have had vasectomies (due to anti-sperm antibodies) are at higher risk of hypersensitivity. * **Paradoxical Effect:** Excessive doses of protamine can actually exert an anticoagulant effect by inhibiting platelets and clotting factors. * **Other Examples of Chemical Antagonism:** Chelating agents (like Dimercaprol for heavy metals) and antacids neutralizing gastric acid.

Q: Which of the following is NOT an example of a Phase II drug metabolic reaction?

Decyclization. Drug metabolism (biotransformation) occurs in two distinct phases to make lipophilic drugs more water-soluble for excretion. **Explanation of the Correct Answer:** **Decyclization** is a **Phase I reaction**. Phase I reactions (Nonsynthetic) involve the introduction or unmasking of a functional group through oxidation, reduction, or hydrolysis. Decyclization specifically refers to the opening of a ring structure (e.g., the metabolism of barbiturates). Other Phase I reactions include Oxidation (most common, via CYP450), Reduction, Hydrolysis, and Cyclization. **Explanation of Incorrect Options:** Phase II reactions (Synthetic/Conjugation) involve attaching an endogenous moiety to the drug to form a highly polar, inactive metabolite. * **A. Acetylation:** A Phase II reaction catalyzed by N-acetyltransferase (NAT). Common examples include Sulfonamides, Isoniazid, and Hydralazine. * **B. Sulfation:** A Phase II reaction where a sulfate group is added (e.g., for Paracetamol or Steroids). * **D. Methylation:** A Phase II reaction involving the addition of a methyl group (e.g., for Adrenaline or Histamine). **High-Yield NEET-PG Pearls:** * **Glucuronidation** is the most common Phase II reaction. * **Microsomal vs. Non-microsomal:** Most Phase I and Glucuronidation enzymes are microsomal (located in the SER). Other Phase II reactions (Acetylation, Sulfation) are primarily **non-microsomal (cytosolic)**. * **Pharmacogenetics:** Acetylation shows genetic polymorphism (Fast vs. Slow acetylators), which is clinically significant for drugs like Isoniazid (risk of peripheral neuropathy in slow acetylators). * **Exception:** While Phase II usually inactivates drugs, **Morphine-6-glucuronide** is a rare example of a Phase II metabolite that is more active than the parent drug.

Q: Which of the following pairs represent physiological antagonists?

Glucagon and Insulin. **Explanation:** **Physiological antagonism** (also known as functional antagonism) occurs when two drugs act on **different receptors** and through **different mechanisms**, but produce **opposite effects** on the same physiological system [1]. **1. Why Glucagon and Insulin is correct:** Glucagon and Insulin act on distinct receptors (Glucagon receptors vs. Insulin tyrosine kinase receptors). However, they exert opposing effects on blood glucose levels: Insulin causes hypoglycemia, while Glucagon causes hyperglycemia [2]. Because they cancel each other's functional effects via different pathways, they are classic physiological antagonists [1]. **2. Why the other options are incorrect:** * **Adrenaline and Isoprenaline (Option A):** Both are adrenergic agonists. They act on similar receptors ($\beta$-receptors) to produce synergistic (additive) effects, not antagonistic ones. * **Isoprenaline and Propranolol (Option C):** This is an example of **Pharmacological (Receptor) Antagonism**. Propranolol is a $eta$-blocker that competes with Isoprenaline for the same $eta$-receptor site [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Example:** The most frequently asked example of physiological antagonism is **Adrenaline and Histamine** on bronchial smooth muscle (Adrenaline causes bronchodilation via $eta_2$ receptors; Histamine causes bronchoconstriction via $H_1$ receptors). * **Chemical Antagonism:** Occurs when two drugs react chemically to form an inactive product (e.g., Chelating agents like EDTA for lead poisoning, or Protamine sulfate for Heparin overdose). * **Pharmacokinetic Antagonism:** One drug reduces the concentration of another by interfering with its absorption, metabolism (e.g., Enzyme inducers like Rifampicin), or excretion.

Q: Which route of drug administration avoids first-pass hepatic metabolism and is used for drug preparations that slowly release drugs for periods as long as seven days?

Transdermal. **Explanation** The correct answer is **Transdermal (Option B)**. **Why Transdermal is Correct:** The transdermal route involves the application of a drug to the skin (usually via a patch) for systemic absorption. It bypasses the gastrointestinal tract and the portal circulation, thereby **avoiding first-pass hepatic metabolism**. A key characteristic of transdermal delivery systems (TDS) is their ability to provide a **controlled, sustained release** of medication. This maintains steady-state plasma concentrations for extended periods, ranging from 24 hours to as long as **seven days** (e.g., Scopolamine or Clonidine patches). **Why Other Options are Incorrect:** * **Topical (A):** While applied to the skin, topical administration is intended for **local effect** (e.g., clotrimazole cream for fungal infections) rather than systemic absorption. * **Sublingual (C):** This route bypasses first-pass metabolism by absorbing drugs directly into the systemic circulation via the sublingual mucosa. However, it is used for **rapid onset** of action (e.g., Nitroglycerin for angina) and cannot provide sustained release for several days. * **Oral (D):** This is the most common route but is subject to significant **first-pass metabolism** in the liver and gut wall. It generally requires frequent dosing compared to long-acting patches. **NEET-PG High-Yield Pearls:** * **Drugs given via Transdermal Patch:** Nitroglycerin, Fentanyl (3 days), Nicotine, Hyoscine (3 days), Granisetron (7 days), and Hormonal contraceptives. * **Ideal Drug Properties for Transdermal Route:** Low molecular weight (<500 Da), high lipid solubility, and high potency (effective at low doses). * **Pro-tip:** The rate-controlling step in transdermal absorption is typically the **stratum corneum** of the epidermis.

Q: A highly ionized drug is characterized by which of the following properties?

It is excreted mainly by the kidney.. **Explanation:** The pharmacokinetics of a drug are heavily influenced by its ionization state. According to the **pH partition hypothesis**, only non-ionized (lipid-soluble) drugs can easily cross biological membranes. **1. Why Option A is Correct:** Highly ionized drugs are **water-soluble (hydrophilic)** and polar. Because they are not lipid-soluble, they cannot easily diffuse back across the renal tubular epithelium into the systemic circulation (tubular reabsorption). Consequently, they remain trapped in the renal tubule and are **excreted mainly by the kidney**. **2. Why the Other Options are Incorrect:** * **Option B:** The placental barrier is a lipid membrane. Highly ionized drugs are lipid-insoluble and therefore **cannot cross the placenta** easily. * **Option C:** Absorption from the intestine requires crossing the lipid bilayer of mucosal cells. Ionized drugs have **poor oral bioavailability** because they cannot penetrate these membranes effectively. * **Option D:** Ionized drugs are lipophobic. They remain in the extracellular fluid or plasma and **do not accumulate in cellular lipids** or adipose tissue. **High-Yield Clinical Pearls for NEET-PG:** * **Ion Trapping:** This principle is used in toxicology. To hasten the excretion of an acidic drug (e.g., Aspirin), we **alkalinize the urine** (using Sodium Bicarbonate). This increases the ionization of the drug in the renal tubules, preventing reabsorption and increasing excretion. * **Blood-Brain Barrier (BBB):** Highly ionized drugs (like quaternary ammonium compounds, e.g., Neostigmine) cannot cross the BBB, whereas non-ionized drugs (e.g., Physostigmine) can. * **Rule of Thumb:** Lipid solubility $\propto$ Non-ionization $\propto$ Better absorption/distribution. Water solubility $\propto$ Ionization $\propto$ Better excretion.

Q: A volunteer is to receive a new drug in a phase I clinical trial. The clearance and the volume of distribution of the drug in the volunteer are 1.386 L/hr and 80 L respectively. What would be the approximate half-life of the drug?

40 hr. The half-life ($t_{1/2}$) of a drug is the time required for its plasma concentration to decrease by 50%. It is a critical pharmacokinetic parameter used to determine dosing intervals and the time required to reach a steady state. **1. Why Option C is Correct:** The relationship between half-life ($t_{1/2}$), Volume of Distribution ($V_d$), and Clearance ($CL$) is defined by the following formula [2]: $t_{1/2} = \frac{0.693 \times V_d}{CL}$ Given values: * $V_d = 80 \text{ L}$ * $CL = 1.386 \text{ L/hr}$ Calculation: $t_{1/2} = \frac{0.693 \times 80}{1.386}$ $t_{1/2} = \frac{55.44}{1.386} = 40 \text{ hours}$ **2. Why Other Options are Incorrect:** * **Option A (83 hr) & B (77 hr):** These values result from calculation errors, such as incorrectly multiplying the variables or using an incorrect constant instead of 0.693. * **Option D (0.02 hr):** This value is obtained if the formula is inverted (Clearance divided by Volume of Distribution), which is mathematically incorrect for calculating half-life. **Clinical Pearls for NEET-PG:** * **Steady State:** It takes approximately **4 to 5 half-lives** for a drug to reach a steady-state concentration ($C_{ss}$) during constant-rate infusion [3], [4]. * **Elimination:** Similarly, it takes about 4 to 5 half-lives for a drug to be effectively eliminated from the body after stopping the drug [3]. * **First-order Kinetics:** In first-order kinetics (most drugs), $t_{1/2}$ remains constant regardless of the dose [1]. In zero-order kinetics (e.g., high-dose Aspirin, Phenytoin, Ethanol), $t_{1/2}$ increases as the dose increases [1]. * **High-Yield Tip:** If you notice that $1.386$ is exactly $2 \times 0.693$, the calculation becomes much faster: $(0.693 \times 80) / (2 \times 0.693) = 80 / 2 = 40$.

Q: The redistribution phenomenon is observed in which of the following drugs?

Thiopentone. **Explanation:** **1. Why Thiopentone is Correct:** Redistribution is the process where a drug moves from its primary site of action (highly perfused organs like the brain) to other tissues (muscle and fat) to achieve equilibrium. **Thiopentone**, a highly lipid-soluble ultra-short-acting barbiturate, exemplifies this. After IV bolus administration, it rapidly enters the brain, causing immediate anesthesia. However, its action terminates within minutes—not because of metabolism, but because the drug **redistributes** from the brain into the skeletal muscles and eventually adipose tissue, lowering the plasma concentration and allowing the patient to wake up. **2. Why Other Options are Incorrect:** * **Halothane and Ether (Options A & B):** These are volatile inhalational anesthetics. Their duration of action is primarily governed by their **solubility in blood** (blood-gas partition coefficient) and elimination via exhalation, rather than redistribution. While some redistribution occurs with all lipid-soluble drugs, it is not the clinically defining mechanism for the termination of action for these gases as it is for Thiopentone. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Context:** Redistribution is a major factor in the termination of action for **highly lipid-soluble** drugs given intravenously in a single bolus. * **Other Examples:** Apart from Thiopentone, **Propofol** and **Fentanyl** also exhibit significant redistribution. * **Cumulative Effect:** If Thiopentone is given as repeated doses or a continuous infusion, the storage sites (muscle/fat) become saturated. In this scenario, the duration of action depends on hepatic metabolism rather than redistribution, leading to prolonged recovery (the "hangover" effect). * **Key Concept:** Redistribution increases the **volume of distribution (Vd)** of a drug over time.

Question 1

Bioavailability is defined as:

Accepted Answer

The fraction of an administered dose of unchanged drug that reaches the systemic circulation

Answer

The extent of drug metabolism in the liver before reaching the systemic circulation

Answer

The extent of drug metabolism in the liver after reaching the systemic circulation

Answer

The fraction of a dose administered via the rectal route that reaches the systemic circulation

Question 2

Which of the following drugs does NOT have high hepatic clearance?

Accepted Answer

Paracetamol

Answer

Labetalol

Answer

Simvastatin

Answer

Morphine

Question 3

The mechanism of action of protamine, an antidote for heparin, is based on which of the following?

Accepted Answer

Chemical antagonism

Answer

Competitive antagonism

Answer

Non-competitive antagonism

Answer

Toxic reaction

Question 4

Which of the following is NOT an example of a Phase II drug metabolic reaction?

Accepted Answer

Decyclization

Answer

Acetylation

Answer

Sulfation

Answer

Methylation

Question 5

Which of the following pairs represent physiological antagonists?

Accepted Answer

Glucagon and Insulin

Answer

Adrenaline and Isoprenaline

Answer

Isoprenaline and Propranolol

Answer

All of the above

Question 6

Which route of drug administration avoids first-pass hepatic metabolism and is used for drug preparations that slowly release drugs for periods as long as seven days?

Accepted Answer

Transdermal

Answer

Topical

Answer

Sublingual

Answer

Oral

Question 7

A highly ionized drug is characterized by which of the following properties?

Accepted Answer

It is excreted mainly by the kidney.

Answer

It can cross the placental barrier easily.

Answer

It is well absorbed from the intestine.

Answer

It accumulates in cellular lipids.

Question 8

A three-year-old child is brought to the emergency department having just ingested a large overdose of an antihistaminic drug. This drug is a weak base capable of entering most tissues, including the brain. On physical examination, the heart rate is 100/minute, blood pressure is 110/60 mm Hg, and the respiratory rate is 20/minute. In this case of poisoning, which of the following is true regarding the management?

Accepted Answer

Urinary excretion would be accelerated by administration of NH4Cl, an acidifying agent.

Answer

Urinary excretion would be accelerated by administration of NaHCO3, an alkalinizing agent.

Answer

More of the drug would be ionized at blood pH than at stomach pH.

Answer

Absorption of the drug would be faster from the stomach than from the small intestine.

Question 9

A volunteer is to receive a new drug in a phase I clinical trial. The clearance and the volume of distribution of the drug in the volunteer are 1.386 L/hr and 80 L respectively. What would be the approximate half-life of the drug?

Accepted Answer

40 hr

Answer

83 hr

Answer

77 hr

Answer

0.02 hr

Question 10

The redistribution phenomenon is observed in which of the following drugs?

Accepted Answer

Thiopentone

Answer

Halothane

Answer

Ether

Answer

All of the above

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?